Health agencies working under Robert F. Kennedy Jr. are making changes to the nation's decades-old system for approving and ...

US stocks took a hit on Monday while Treasury yields rose, as Wall Street processed Moody's downgrade of the US credit rating ...

In other vaccine news, Health Secretary Robert F. Kennedy Jr. has officially ordered placebo testing on new vaccines, a change that experts claim will be costly and — harkening back to polio vaccine ...

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do ...

The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...

" Hello people! I've been tested positive for COVID. Stay safe and wear your masks!," Shilpa wrote, urging people to take precautionary measures as a new wave of COVID-19 has emerged in several ...

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

Novavax Inc. jumped in early trading after US regulators fully approved its Covid vaccine, easing investors’ concerns after ...

(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...

Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...

Several Asian countries are witnessing a fresh surge in Covid-19 cases, driven by the fast-spreading JN.1 variant and its ...